cancer

FDA Approves New Breast Cancer Drug

Novartis AG’s combination therapy of hormone therapy for postmenopausal women, as well as for men, with a form of advanced breast cancer has been approved by the U.S. Food and Drug Administration (FDA).

LKP Website
loading